Medical professionals play a very important role in the society. They ensure that we are free from diseases, in order to lead a quality life. Each and every day, they strive to make new developments in the industry, trying to solve the common health issues that affect our societies today. One of the most notable leaders in the healthcare industry is Clay Siegall.
Clay Siegall is trained scientist with a special interest in cancer therapies. The award-winning biotechnology expert is the Co-founder and Chief Executive Officer of Seattle Genetics. The primary focus of the company is to focus on bettering their patients. Clay Siegall talked to Ideamensch telling them on what led to him being interested in co-founding Seattle Genetics. He talked of how he watched his father die slowly, from cancer, and the limited oncological resources could not help him. Therefore, he was determined to pursue a career where he would help in improving the tools, hoping that someone else’s life might be saved.
Therefore, when Clay Siegall went to University of Maryland, he pursued a Bachelor’s degree of Science in Zoology. And, to sharpen his knowledge in the biotechnology field, he furthered his education in George Washington University, graduating with a doctorate in Genetics. Clay Siegall told Ideamensch that nothing gives him more joy than to wake up every day knowing that he influences the lives of others in a positive way. His aim is to ensure that tomorrow, there will even be better tools to treat Cancer.
Prior to co-founding Seattle Genetics, Clay Siegall worked for National Cancer Institute, National Institutes of Health. He has worked for the company since the year 1988 to the year 1997. He also worked for Bristol-Myers Squibb Pharmaceutical Research Institute and was with the company for a period of 6 years.
Other than being in the leadership team of Seattle Genetics, Clay Siegall is an author. He has published more than 70 articles. Also, he holds more than 20 patents